Hybio Pharmaceutical (300199) — Cash Flow Reinvestment Rate
Hybio Pharmaceutical (300199) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting CN¥95.60 Million (capex CN¥95.60 Million ) from operating cash flow of CN¥117.78 Million. Explore capital reinvestment ratio of Hybio Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hybio Pharmaceutical Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Hybio Pharmaceutical across 17 annual periods. Also explore 300199 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hybio Pharmaceutical (2007–2024)
Year-by-year capital reinvestment analysis for Hybio Pharmaceutical. For live market cap and broader valuation context, see 300199 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥116.14 Million | CN¥164.71 Million | CN¥115.84 Million | ▼ -97.1% |
| 2022 | 24.36x | CN¥385.14 Million | CN¥15.81 Million | CN¥189.85 Million | ▲ +1635.3% |
| 2021 | 1.40x | CN¥220.20 Million | CN¥156.83 Million | CN¥199.00 Million | ▼ -73.9% |
| 2020 | 5.39x | CN¥258.66 Million | CN¥47.99 Million | CN¥243.66 Million | ▼ -7.0% |
| 2019 | 5.80x | CN¥606.40 Million | CN¥104.64 Million | CN¥570.15 Million | ▼ -36.0% |
| 2018 | 9.06x | CN¥425.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▲ +771.3% |
| 2017 | 1.04x | CN¥222.14 Million | CN¥213.74 Million | CN¥221.14 Million | ▲ +133.7% |
| 2016 | 0.44x | CN¥131.80 Million | CN¥296.41 Million | CN¥116.05 Million | ▼ -94.5% |
| 2015 | 8.09x | CN¥1.12 Billion | CN¥138.84 Million | CN¥358.98 Million | ▲ +1358.1% |
| 2014 | 0.56x | CN¥85.16 Million | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥302.85 Million | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥221.38 Million | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥78.27 Million | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥22.83 Million | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥9.01 Million | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥60.28 Million | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥4.90 Million | CN¥49.04 Million | CN¥4.90 Million | — |